-
Insights into the evolution of Chinese second medical use patent claims
24 Oct 2025 09:17 GMT
… feature related to drug administration during treatment. Without altering the drug’s preparation … confer novelty to the claimed pharmaceutical use and thus was not … “Use of degarelix in the manufacture of a medicament for treating metastatic …
-
Gonadotropin-Releasing Hormone (GnRH) Agonists & Antagonists Drugs Market Report 2025: Trends, Drivers & Forecasts
21 Aug 2025 13:16 GMT
… agonists and antagonists medication is expected to … reproductive treatments, advancements in clinical trial designs … .
• AstraZeneca plc
• Takeda Pharmaceutical Company Limited
• Merck KGaA
… GnRH Antagonists, Degarelix, Abarelix, Other Drug Types
2) By …
-
What is chemical castration? Here's why doctors will be uneasy about using it on sex offenders
22 May 2025 10:41 GMT
… a clinical trial in Stockholm, Sweden, of a drug called degarelix.
Results … .
But like other clinical trials, it was relatively small … to be considering making treatment compulsory for serious sex … be deeply controversial with the medical profession in the UK. …
-
Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US.
08 Apr 2025 11:49 GMT
… persistence and adherence of relugolix, degarelix, and GnRH agonists (leuprolide, … lower testosterone. A large clinical trial (phase III) showed relugolix rapidly … patients stay on treatment (persistence) and take their medication as prescribed (adherence …
-
Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research
07 Oct 2025 01:00 GMT
… immediate testosterone suppression. Degarelix and relugolix are … pharmaceutical players are fostering clinical trials and new drug approvals … cancer screening, while biotech firms are forming … to attract medical tourism and regional treatment demand.
…
-
BIR adds 16 medicines for cancer, diabetes, mental illness to VAT-exempt list
16 Dec 2024 11:13 GMT
… 12 of the law, prescription drugs and medicines for diabetes, high cholesterol … following medicines are now VAT-exempt:
Cancer
Degarelix 80 mg
Degarelix 120 mg … endorsed by the Food and Drug Administration (FDA) to the BIR on …
-
Peptide Cancer Drug Research Report 2024: $18 Billion Market Opportunities, Dosage, Drug Price, Sales & Clinical Trials Insights to 2030 - ResearchAndMarkets.com
09 Dec 2024 13:57 GMT
… drugs, is anticipated to lead to more effective treatment regimens.
Recent clinical trials … octreotide, another approved peptide medication, has demonstrated significant … )
5.4 Gonax (Degarelix Acetate)
5.5 Trelstar …
15.1 3B Pharmaceuticals
15.2 AsclepiX …
-
FDA exempts 17 more medicines from VAT
25 Nov 2024 22:34 GMT
… Food and Drug Administration (FDA) has added 17 more medicines to the list … of VAT-exempted medicines. Under the law, the FDA must provide an … -exempt drugs are Degarelix (80 milligrams and 120 mg) used for the treatment …
-
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer.
19 Nov 2024 09:22 GMT
… and antagonists (e.g., degarelix) administered via muscular or … safety results of this trial, and key points … podcast is to help doctors and patients learn … Treatment for advanced prostate cancer often includes lowering testosterone levels through medicines …
-
16 more drugs exempted from VAT
26 Nov 2024 20:07 GMT
… the list are medicines for cancer, namely degarelix 80 milligrams, degarelix 120 mg … gonadotrophin).
The FDA explained that the drug is indicated as treatment for “anovulatory …